Advertisement
Review Article| Volume 33, ISSUE 4, P1003-1025, December 2019

Chikungunya

Epidemiology, Pathogenesis, Clinical Features, Management, and Prevention

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Infectious Disease Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Diallo M.
        • Thonnon J.
        • Traore-Lamizana M.
        • et al.
        Vectors of Chikungunya virus in Senegal: current data and transmission cycles.
        Am J Trop Med Hyg. 1999; 60: 281-286
        • Mason P.J.
        • Haddow A.J.
        An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53; an additional note on Chikungunya virus isolations and serum antibodies.
        Trans R Soc Trop Med Hyg. 1957; 51: 238-240
        • Ross R.W.
        The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic.
        J Hyg (Lond). 1956; 54: 177-191
        • Weaver S.C.
        • Forrester N.L.
        Chikungunya: evolutionary history and recent epidemic spread.
        Antiviral Res. 2015; 120: 32-39
        • Weinbren M.P.
        The occurrence of Chikungunya virus in Uganda. II. In man on the Entebbe peninsula.
        Trans R Soc Trop Med Hyg. 1958; 52: 258-259
        • Powers A.M.
        • Brault A.C.
        • Tesh R.B.
        • et al.
        Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships.
        J Gen Virol. 2000; 81: 471-479
        • Volk S.M.
        • Chen R.
        • Tsetsarkin K.A.
        • et al.
        Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates.
        J Virol. 2010; 84: 6497-6504
        • Tsetsarkin K.A.
        • Chen R.
        • Leal G.
        • et al.
        Chikungunya virus emergence is constrained in Asia by lineage-specific adaptive landscapes.
        Proc Natl Acad Sci U S A. 2011; 108: 7872-7877
        • Nunes M.R.
        • Faria N.R.
        • de Vasconcelos J.M.
        • et al.
        Emergence and potential for spread of Chikungunya virus in Brazil.
        BMC Med. 2015; 13: 102
        • Mourya D.T.
        • Thakare J.R.
        • Gokhale M.D.
        • et al.
        Isolation of chikungunya virus from Aedes aegypti mosquitoes collected in the town of Yawat, Pune District, Maharashtra State, India.
        Acta Virol. 2001; 45: 305-309
        • Rausalu K.
        • Utt A.
        • Quirin T.
        • et al.
        Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease's active site cysteine residue.
        Sci Rep. 2016; 6: 37124
        • Metz S.W.
        • Pijlman G.P.
        Production of Chikungunya virus-like particles and subunit vaccines in insect cells.
        Methods Mol Biol. 2016; 1426: 297-309
        • Khan A.H.
        • Morita K.
        • Parquet M.D.
        • et al.
        Complete nucleotide sequence of chikungunya virus and evidence for an internal polyadenylation site.
        J Gen Virol. 2002; 83: 3075-3084
        • Voss J.E.
        • Vaney M.C.
        • Duquerroy S.
        • et al.
        Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography.
        Nature. 2010; 468: 709-712
        • Snyder A.J.
        • Sokoloski K.J.
        • Mukhopadhyay S.
        Mutating conserved cysteines in the alphavirus e2 glycoprotein causes virus-specific assembly defects.
        J Virol. 2012; 86: 3100-3111
        • Melton J.V.
        • Ewart G.D.
        • Weir R.C.
        • et al.
        Alphavirus 6K proteins form ion channels.
        J Biol Chem. 2002; 277: 46923-46931
        • Snyder J.E.
        • Kulcsar K.A.
        • Schultz K.L.
        • et al.
        Functional characterization of the alphavirus TF protein.
        J Virol. 2013; 87: 8511-8523
        • Solignat M.
        • Gay B.
        • Higgs S.
        • et al.
        Replication cycle of chikungunya: a re-emerging arbovirus.
        Virology. 2009; 393: 183-197
        • Lum F.M.
        • Ng L.F.
        Cellular and molecular mechanisms of chikungunya pathogenesis.
        Antiviral Res. 2015; 120: 165-174
        • Rupp J.C.
        • Sokoloski K.J.
        • Gebhart N.N.
        • et al.
        Alphavirus RNA synthesis and non-structural protein functions.
        J Gen Virol. 2015; 96: 2483-2500
        • Powers A.M.
        Vaccine and therapeutic options to control Chikungunya virus.
        Clin Microbiol Rev. 2017; 31 ([pii:e00104-16])
        • Fortuna C.
        • Remoli M.E.
        • Rizzo C.
        • et al.
        Imported arboviral infections in Italy, July 2014-October 2015: a National Reference Laboratory report.
        BMC Infect Dis. 2017; 17: 216
        • Wahid B.
        • Ali A.
        • Rafique S.
        • et al.
        Global expansion of chikungunya virus: mapping the 64-year history.
        Int J Infect Dis. 2017; 58: 69-76
        • Sergon K.
        • Yahaya A.A.
        • Brown J.
        • et al.
        Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005.
        Am J Trop Med Hyg. 2007; 76: 1189-1193
        • Josseran L.
        • Paquet C.
        • Zehgnoun A.
        • et al.
        Chikungunya disease outbreak, Reunion Island.
        Emerg Infect Dis. 2006; 12: 1994-1995
        • Grandadam M.
        • Caro V.
        • Plumet S.
        • et al.
        Chikungunya virus, southeastern France.
        Emerg Infect Dis. 2011; 17: 910-913
        • Rezza G.
        • Nicoletti L.
        • Angelini R.
        • et al.
        Infection with chikungunya virus in Italy: an outbreak in a temperate region.
        Lancet. 2007; 370: 1840-1846
        • Delisle E.
        • Rousseau C.
        • Broche B.
        • et al.
        Chikungunya outbreak in Montpellier, France, September to October 2014.
        Euro Surveill. 2015; 20https://doi.org/10.2807/1560-7917.es2015.20.17.21108
        • Calba C.
        • Guerbois-Galla M.
        • Franke F.
        • et al.
        Preliminary report of an autochthonous chikungunya outbreak in France, July to September 2017.
        Euro Surveill. 2017; 22https://doi.org/10.2807/1560-7917.ES.2017.22.39.17-00647
        • Vairo F.
        • Mammone A.
        • Lanini S.
        • et al.
        Local transmission of chikungunya in Rome and the Lazio region, Italy.
        PLoS One. 2018; 13: e0208896
        • Bordi L.
        • Carletti F.
        • Lalle E.
        • et al.
        Molecular characterization of autochthonous Chikungunya cluster in Latium region, Italy.
        Emerg Infect Dis. 2018; 24https://doi.org/10.3201/eid2401.171605
        • Diallo D.
        • Sall A.A.
        • Buenemann M.
        • et al.
        Landscape ecology of sylvatic chikungunya virus and mosquito vectors in southeastern Senegal.
        PLoS Negl Trop Dis. 2012; 6: e1649
        • Jupp P.G.
        • McIntosh B.M.
        Aedes furcifer and other mosquitoes as vectors of chikungunya virus at Mica, northeastern Transvaal, South Africa.
        J Am Mosq Control Assoc. 1990; 6: 415-420
        • Coffey L.L.
        • Failloux A.B.
        • Weaver S.C.
        Chikungunya virus-vector interactions.
        Viruses. 2014; 6: 4628-4663
        • Gubler D.J.
        The global emergence/resurgence of arboviral diseases as public health problems.
        Arch Med Res. 2002; 33: 330-342
        • Lounibos L.P.
        Invasions by insect vectors of human disease.
        Annu Rev Entomol. 2002; 47: 233-266
        • Powers A.M.
        • Logue C.H.
        Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus.
        J Gen Virol. 2007; 88: 2363-2377
        • Schuffenecker I.
        • Iteman I.
        • Michault A.
        • et al.
        Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak.
        PLoS Med. 2006; 3: e263
        • Tsetsarkin K.A.
        • Vanlandingham D.L.
        • McGee C.E.
        • et al.
        A single mutation in chikungunya virus affects vector specificity and epidemic potential.
        PLoS Pathog. 2007; 3: e201
        • Vashishtha M.
        • Phalen T.
        • Marquardt M.T.
        • et al.
        A single point mutation controls the cholesterol dependence of Semliki Forest virus entry and exit.
        J Cell Biol. 1998; 140: 91-99
        • Venturi G.
        • Di Luca M.
        • Fortuna C.
        • et al.
        Detection of a chikungunya outbreak in Central Italy, August to September 2017.
        Euro Surveill. 2017; 22https://doi.org/10.2807/1560-7917.ES.2017.22.39.17-00646
        • Bordi L.
        • Carletti F.
        • Castilletti C.
        • et al.
        Presence of the A226V mutation in autochthonous and imported Italian chikungunya virus strains.
        Clin Infect Dis. 2008; 47: 428-429
        • Tsetsarkin K.A.
        • Chen R.
        • Yun R.
        • et al.
        Multi-peaked adaptive landscape for chikungunya virus evolution predicts continued fitness optimization in Aedes albopictus mosquitoes.
        Nat Commun. 2014; 5: 4084
        • Tsetsarkin K.A.
        • McGee C.E.
        • Volk S.M.
        • et al.
        Epistatic roles of E2 glycoprotein mutations in adaption of chikungunya virus to Aedes albopictus and Ae. aegypti mosquitoes.
        PLoS One. 2009; 4: e6835
        • Horwood P.F.
        • Buchy P.
        Chikungunya. (Special Issue: New developments in major vector-borne diseases. Part II: important diseases for veterinarians.).
        Sci Tech Rev Off Int Epiz. 2015; 34: 479-489
        • Mavale M.
        • Parashar D.
        • Sudeep A.
        • et al.
        Venereal transmission of chikungunya virus by Aedes aegypti mosquitoes (Diptera: Culicidae).
        Am J Trop Med Hyg. 2010; 83: 1242-1244
        • Agarwal A.
        • Dash P.K.
        • Singh A.K.
        • et al.
        Evidence of experimental vertical transmission of emerging novel ECSA genotype of Chikungunya Virus in Aedes aegypti.
        PLoS Negl Trop Dis. 2014; 8: e2990
        • Chompoosri J.
        • Thavara U.
        • Tawatsin A.
        • et al.
        Vertical transmission of Indian Ocean Lineage of chikungunya virus in Aedes aegypti and Aedes albopictus mosquitoes.
        Parasit Vectors. 2016; 9: 227
        • Jain J.
        • Kushwah R.B.S.
        • Singh S.S.
        • et al.
        Evidence for natural vertical transmission of chikungunya viruses in field populations of Aedes aegypti in Delhi and Haryana states in India-a preliminary report.
        Acta Trop. 2016; 162: 46-55
        • Furuya-Kanamori L.
        • Liang S.
        • Milinovich G.
        • et al.
        Co-distribution and co-infection of chikungunya and dengue viruses.
        BMC Infect Dis. 2016; 16: 84
        • Boga J.A.
        • Alvarez-Arguelles M.E.
        • Rojo-Alba S.
        • et al.
        Simultaneous detection of Dengue virus, Chikungunya virus, Zika virus, Yellow fever virus and West Nile virus.
        J Virol Methods. 2019; 268: 53-55
        • Appassakij H.
        • Khuntikij P.
        • Kemapunmanus M.
        • et al.
        Viremic profiles in asymptomatic and symptomatic chikungunya fever: a blood transfusion threat?.
        Transfusion. 2013; 53: 2567-2574
        • Brouard C.
        • Bernillon P.
        • Quatresous I.
        • et al.
        Estimated risk of Chikungunya viremic blood donation during an epidemic on Reunion Island in the Indian Ocean, 2005 to 2007.
        Transfusion. 2008; 48: 1333-1341
        • Liumbruno G.M.
        • Calteri D.
        • Petropulacos K.
        • et al.
        The Chikungunya epidemic in Italy and its repercussion on the blood system.
        Blood Transfus. 2008; 6: 199-210
        • Kee A.C.
        • Yang S.
        • Tambyah P.
        Atypical chikungunya virus infections in immunocompromised patients.
        Emerg Infect Dis. 2010; 16: 1038-1040
        • Dalla Gasperina D.
        • Balsamo M.L.
        • Garavaglia S.D.
        • et al.
        Chikungunya infection in a human immunodeficiency virus-infected kidney transplant recipient returning to Italy from the Dominican Republic.
        Transpl Infect Dis. 2015; 17: 876-879
        • Girão E.S.
        • Rodrigues Dos Santos B.G.
        • do Amaral E.S.
        • et al.
        Chikungunya infection in solid organ transplant recipients.
        Transpl Proc. 2017; 49: 2076-2081
        • Couderc T.
        • Gangneux N.
        • Chrétien F.
        • et al.
        Chikungunya virus infection of corneal grafts.
        J Infect Dis. 2012; 206: 851-859
        • Gérardin P.
        • Barau G.
        • Michault A.
        • et al.
        Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion.
        PLoS Med. 2008; 5: e60
        • Couderc T.
        • Chrétien F.
        • Schilte C.
        • et al.
        A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease.
        PLoS Pathog. 2008; 4: e29
        • Contopoulos-Ioannidis D.
        • Newman-Lindsay S.
        • Chow C.
        • et al.
        Mother-to-child transmission of Chikungunya virus: a systematic review and meta-analysis.
        PLoS Negl Trop Dis. 2018; 12: e0006510
        • Patterson J.
        • Sammon M.
        • Garg M.
        Dengue, Zika and Chikungunya: emerging arboviruses in the new world.
        West J Emerg Med. 2016; 17: 671-679
        • Bandeira A.C.
        • Campos G.S.
        • Rocha V.F.
        • et al.
        Prolonged shedding of Chikungunya virus in semen and urine: a new perspective for diagnosis and implications for transmission.
        IDCases. 2016; 6: 100-103
        • Matusali G.
        • Colavita F.
        • Bordi L.
        • et al.
        Tropism of the Chikungunya Virus.
        Viruses. 2019; 11 ([pii:E175])
        • Sourisseau M.
        • Schilte C.
        • Casartelli N.
        • et al.
        Characterization of reemerging chikungunya virus.
        PLoS Pathog. 2007; 3: e89
        • Kam Y.W.
        • Ong E.K.
        • Rénia L.
        • et al.
        Immuno-biology of Chikungunya and implications for disease intervention.
        Microbes Infect. 2009; 11: 1186-1196
        • Lohachanakul J.
        • Phuklia W.
        • Thannagith M.
        • et al.
        Differences in response of primary human myoblasts to infection with recent epidemic strains of Chikungunya virus isolated from patients with and without myalgia.
        J Med Virol. 2015; 87: 733-739
        • Hoarau J.J.
        • Jaffar Bandjee M.C.
        • Krejbich Trotot P.
        • et al.
        Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response.
        J Immunol. 2010; 184: 5914-5927
        • Zhang X.
        • Huang Y.
        • Wang M.
        • et al.
        Differences in genome characters and cell tropisms between two chikungunya isolates of Asian lineage and Indian Ocean lineage.
        Virol J. 2018; 15: 130
        • Lokireddy S.
        • Vemula S.
        • Vadde R.
        Connective tissue metabolism in chikungunya patients.
        Virol J. 2008; 5: 31
        • Chow A.
        • Her Z.
        • Ong E.K.
        • et al.
        Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor.
        J Infect Dis. 2011; 203: 149-157
        • Goupil B.A.
        • McNulty M.A.
        • Martin M.J.
        • et al.
        Novel lesions of bones and joints associated with Chikungunya virus infection in two mouse models of disease: new insights into disease pathogenesis.
        PLoS One. 2016; 11: e0155243
        • Yoon I.K.
        • Alera M.T.
        • Lago C.B.
        • et al.
        High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.
        PLoS Negl Trop Dis. 2015; 9: e0003764
        • Burt F.J.
        • Chen W.
        • Miner J.J.
        • et al.
        Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen.
        Lancet Infect Dis. 2017; 17: e107-e117
        • Morrison T.E.
        Reemergence of chikungunya virus.
        J Virol. 2014; 88: 11644-11647
        • Colavita F.
        • Vita S.
        • Lalle E.
        • et al.
        Overproduction of IL-6 and type-I IFN in a lethal case of Chikungunya virus infection in an elderly man during the 2017 Italian outbreak.
        Open Forum Infect Dis. 2018; 5: ofy276
        • Mehta R.
        • Gerardin P.
        • de Brito C.A.A.
        • et al.
        The neurological complications of chikungunya virus: a systematic review.
        Rev Med Virol. 2018; 28: e1978
        • Dhanwani R.
        • Khan M.
        • Bhaskar A.S.
        • et al.
        Characterization of Chikungunya virus infection in human neuroblastoma SH-SY5Y cells: role of apoptosis in neuronal cell death.
        Virus Res. 2012; 163: 563-572
        • Abere B.
        • Wikan N.
        • Ubol S.
        • et al.
        Proteomic analysis of chikungunya virus infected microglial cells.
        PLoS One. 2012; 7: e34800
        • Abraham R.
        • Mudaliar P.
        • Padmanabhan A.
        • et al.
        Induction of cytopathogenicity in human glioblastoma cells by chikungunya virus.
        PLoS One. 2013; 8: e75854
        • Thiberville S.D.
        • Moyen N.
        • Dupuis-Maguiraga L.
        • et al.
        Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy.
        Antiviral Res. 2013; 99: 345-370
        • Capeding M.R.
        • Chua M.N.
        • Hadinegoro S.R.
        • et al.
        Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children.
        PLoS Negl Trop Dis. 2013; 7: e2331
        • Simon F.
        • Javelle E.
        • Oliver M.
        • et al.
        Chikungunya virus infection.
        Curr Infect Dis Rep. 2011; 13: 218-228
        • Rahman M.
        • Yamagishi J.
        • Rahim R.
        • et al.
        East/Central/South African Genotype in a Chikungunya Outbreak, Dhaka, Bangladesh, 2017.
        Emerg Infect Dis. 2019; 25: 370-372
        • de Andrade G.C.
        • Ventura C.V.
        • Mello Filho P.A.
        • et al.
        Arboviruses and the eye.
        Int J Retina Vitreous. 2017; 3: 4
        • Simon F.
        • Javelle E.
        • Cabie A.
        • et al.
        French guidelines for the management of chikungunya (acute and persistent presentations). November 2014.
        Med Mal Infect. 2015; 45: 243-263
        • Ramful D.
        • Carbonnier M.
        • Pasquet M.
        • et al.
        Mother-to-child transmission of Chikungunya virus infection.
        Pediatr Infect Dis J. 2007; 26: 811-815
        • Torres J.R.
        • Falleiros-Arlant L.H.
        • Dueñas L.
        • et al.
        Congenital and perinatal complications of chikungunya fever: a Latin American experience.
        Int J Infect Dis. 2016; 51: 85-88
        • Gérardin P.
        • Sampériz S.
        • Ramful D.
        • et al.
        Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: the CHIMERE cohort study on Reunion Island.
        PLoS Negl Trop Dis. 2014; 8: e2996
        • Tandale B.V.
        • Sathe P.S.
        • Arankalle V.A.
        • et al.
        Systemic involvements and fatalities during Chikungunya epidemic in India, 2006.
        J Clin Virol. 2009; 46: 145-149
        • Crosby L.
        • Perreau C.
        • Madeux B.
        • et al.
        Severe manifestations of chikungunya virus in critically ill patients during the 2013-2014 Caribbean outbreak.
        Int J Infect Dis. 2016; 48: 78-80
        • Lemant J.
        • Boisson V.
        • Winer A.
        • et al.
        Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006.
        Crit Care Med. 2008; 36: 2536-2541
        • Economopoulou A.
        • Dominguez M.
        • Helynck B.
        • et al.
        Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion.
        Epidemiol Infect. 2009; 137: 534
        • Gérardin P.
        • Couderc T.
        • Bintner M.
        • et al.
        Chikungunya virus-associated encephalitis: a cohort study on La Réunion Island, 2005-2009.
        Neurology. 2016; 86: 94-102
        • Chusri S.
        • Siripaitoon P.
        • Hirunpat S.
        • et al.
        Case reports of neuro-Chikungunya in southern Thailand.
        Am J Trop Med Hyg. 2011; 85: 386-389
        • Charrel R.N.
        • de Lamballerie X.
        • Raoult D.
        Chikungunya outbreaks—the globalization of vectorborne diseases.
        N Engl J Med. 2007; 356: 769-771
        • Couderc T.
        • Khandoudi N.
        • Grandadam M.
        • et al.
        Prophylaxis and therapy for Chikungunya virus infection.
        J Infect Dis. 2009; 200: 516-523
        • Khan M.
        • Santhosh S.R.
        • Tiwari M.
        • et al.
        Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells.
        J Med Virol. 2010; 82: 817-824
        • Pohjala L.
        • Utt A.
        • Varjak M.
        • et al.
        Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.
        PLoS One. 2011; 6: e28923
        • Kaur P.
        • Thiruchelvan M.
        • Lee R.C.
        • et al.
        Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression.
        Antimicrob Agents Chemother. 2013; 57: 155-167
        • Bourjot M.
        • Leyssen P.
        • Neyts J.
        • et al.
        Trigocherrierin A, a potent inhibitor of chikungunya virus replication.
        Molecules. 2014; 19: 3617-3627
        • Albulescu I.C.
        • Tas A.
        • Scholte F.E.
        • et al.
        An in vitro assay to study chikungunya virus RNA synthesis and the mode of action of inhibitors.
        J Gen Virol. 2014; 95: 2683-2692
        • Schilte C.
        • Couderc T.
        • Chretien F.
        • et al.
        Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.
        J Exp Med. 2010; 207: 429-442
        • Mallilankaraman K.
        • Shedlock D.J.
        • Bao H.
        • et al.
        A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates.
        PLoS Negl Trop Dis. 2011; 5: e928
        • Tretyakova I.
        • Hearn J.
        • Wang E.
        • et al.
        DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.
        J Infect Dis. 2014; 209: 1882-1890
        • Wang E.
        • Volkova E.
        • Adams A.P.
        • et al.
        Chimeric alphavirus vaccine candidates for chikungunya.
        Vaccine. 2008; 26: 5030-5039
        • Hallengärd D.
        • Kakoulidou M.
        • Lulla A.
        • et al.
        Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.
        J Virol. 2014; 88: 2858-2866
        • Chattopadhyay A.
        • Wang E.
        • Seymour
        • et al.
        A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.
        J Virol. 2013; 87: 395-402
        • Plante K.
        • Wang E.
        • Partidos C.D.
        • et al.
        Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism.
        PLoS Pathog. 2011; 7: e1002142
        • Levitt N.H.
        • Ramsburg H.H.
        • Hasty S.E.
        • et al.
        Development of an attenuated strain of chikungunya virus for use in vaccine production.
        Vaccine. 1986; 4: 157-162
        • Edelman R.
        • Tacket C.O.
        • Wasserman S.S.
        • et al.
        Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.
        Am J Trop Med Hyg. 2000; 62: 681-685
        • Chang L.J.
        • Dowd K.A.
        • Mendoza F.H.
        • et al.
        Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial.
        Lancet. 2014; 384: 2046-2052
        • Ramsauer K.
        • Schwameis M.
        • Firbas C.
        • et al.
        Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial.
        Lancet Infect Dis. 2015; 15: 519-527
        • Reisinger E.C.
        • Tschismarov R.
        • Beubler E.
        • et al.
        Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial.
        Lancet. 2019; 392: 2718-2727
        • Zumla A.
        • Dar O.
        • Kock R.
        • et al.
        Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential.
        Int J Infect Dis. 2016; 47: 5-9
        • McCloskey B.
        • Dar O.
        • Zumla A.
        • et al.
        Emerging infectious diseases and pandemic potential: status quo and reducing risk of global spread.
        Lancet Infect Dis. 2014; 14: 1001-1010